Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Association between a functional variant of the KLOTHO gene and high-density lipoprotein cholesterol, blood pressure, stroke, and longevity

DE. Arking, G. Atzmon, A. Arking, N. Barzilai, HC. Dietz,

. 2005 ; 96 (4) : 412-418. [pub] 20050127

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem, Research Support, U.S. Gov't, P.H.S.

Perzistentní odkaz   https://www.medvik.cz/link/bmc20013827

Grantová podpora
DK 20541 NIDDK NIH HHS - United States
M01-RR12248 NCRR NIH HHS - United States
MH070172 NIMH NIH HHS - United States
P01 AG-03949-01A1 NIA NIH HHS - United States
R01 AG-18728-01A1 NIA NIH HHS - United States

We previously identified a functional variant of KLOTHO, termed KL-VS, that is associated with human aging and early-onset occult coronary artery disease. Here, we determine whether the KL-VS allele influences cardiovascular disease risk factors, cardiovascular events, and ultimately, mortality. A total of 525 Ashkenazi Jews composed of 216 probands (age > or =95 years) and 309 unrelated individuals (ages 51 to 94) were genotyped for the KL-VS allele. In concordance with our previous data in Czech individuals (age > or =79; P<0.01), a heterozygous advantage for longevity was observed for individuals > or =79 years of age (P<0.004). Combined analysis indicates a 1.57-fold (95% CI, 1.23 to 1.98) increased odds ratio (OR) for 5-year survival in two independent populations (P<0.0002). Cardiovascular disease risk factors were assessed through multivariate regression analysis, demonstrating that high-density lipoprotein cholesterol (HDL-C; P<0.05) and systolic blood pressure (SBP; P<0.008) are associated with KL-VS genotype. History of vascular events was analyzed using logistic regression, indicating that after adjustment for traditional risk factors, heterozygous individuals were at significantly lower risk for stroke than wild-type individuals (OR, 5.88; 95% CI, 1.18 to 29.41), whereas homozygous KL-VS individuals had the highest risk (OR, 30.65; 95% CI, 2.55 to 368.00). Similarly, prospective analysis of mortality in probands using Cox regression indicates that wild-type individuals have a 2.15-fold (95% CI, 1.18 to 3.91) and homozygous KL-VS individuals a 4.49-fold (95% CI, 1.35 to 14.97) increase in relative risk for mortality after adjusting for potential confounders. Thus, cross-sectional and prospective studies confirm a genetic model in which the KL-VS allele confers a heterozygous advantage in conjunction with a marked homozygous disadvantage for HDL-C levels, SBP, stroke, and longevity.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20013827
003      
CZ-PrNML
005      
20200915104408.0
007      
ta
008      
200911s2005 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1161/01.RES.0000157171.04054.30 $2 doi
035    __
$a (PubMed)15677572
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Arking, Dan E $u McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Md 21205, USA.
245    10
$a Association between a functional variant of the KLOTHO gene and high-density lipoprotein cholesterol, blood pressure, stroke, and longevity / $c DE. Arking, G. Atzmon, A. Arking, N. Barzilai, HC. Dietz,
520    9_
$a We previously identified a functional variant of KLOTHO, termed KL-VS, that is associated with human aging and early-onset occult coronary artery disease. Here, we determine whether the KL-VS allele influences cardiovascular disease risk factors, cardiovascular events, and ultimately, mortality. A total of 525 Ashkenazi Jews composed of 216 probands (age > or =95 years) and 309 unrelated individuals (ages 51 to 94) were genotyped for the KL-VS allele. In concordance with our previous data in Czech individuals (age > or =79; P<0.01), a heterozygous advantage for longevity was observed for individuals > or =79 years of age (P<0.004). Combined analysis indicates a 1.57-fold (95% CI, 1.23 to 1.98) increased odds ratio (OR) for 5-year survival in two independent populations (P<0.0002). Cardiovascular disease risk factors were assessed through multivariate regression analysis, demonstrating that high-density lipoprotein cholesterol (HDL-C; P<0.05) and systolic blood pressure (SBP; P<0.008) are associated with KL-VS genotype. History of vascular events was analyzed using logistic regression, indicating that after adjustment for traditional risk factors, heterozygous individuals were at significantly lower risk for stroke than wild-type individuals (OR, 5.88; 95% CI, 1.18 to 29.41), whereas homozygous KL-VS individuals had the highest risk (OR, 30.65; 95% CI, 2.55 to 368.00). Similarly, prospective analysis of mortality in probands using Cox regression indicates that wild-type individuals have a 2.15-fold (95% CI, 1.18 to 3.91) and homozygous KL-VS individuals a 4.49-fold (95% CI, 1.35 to 14.97) increase in relative risk for mortality after adjusting for potential confounders. Thus, cross-sectional and prospective studies confirm a genetic model in which the KL-VS allele confers a heterozygous advantage in conjunction with a marked homozygous disadvantage for HDL-C levels, SBP, stroke, and longevity.
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a alely $7 D000483
650    _2
$a substituce aminokyselin $7 D019943
650    _2
$a krevní tlak $x genetika $7 D001794
650    _2
$a kardiovaskulární nemoci $x epidemiologie $7 D002318
650    _2
$a HDL-cholesterol $x krev $7 D008076
650    _2
$a průřezové studie $7 D003430
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genetická predispozice k nemoci $7 D020022
650    _2
$a genetická variace $7 D014644
650    _2
$a genotyp $7 D005838
650    _2
$a lidé $7 D006801
650    _2
$a židé $x genetika $7 D007585
650    _2
$a dlouhověkost $x genetika $7 D008136
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a modely genetické $7 D008957
650    _2
$a multivariační analýza $7 D015999
650    _2
$a missense mutace $7 D020125
650    _2
$a odds ratio $7 D016017
650    _2
$a proporcionální rizikové modely $7 D016016
650    _2
$a prospektivní studie $7 D011446
650    _2
$a rizikové faktory $7 D012307
650    _2
$a selekce (genetika) $7 D012641
650    _2
$a cévní mozková příhoda $x genetika $7 D020521
650    _2
$a analýza přežití $7 D016019
651    _2
$a Česká republika $x epidemiologie $7 D018153
651    _2
$a východní Evropa $x etnologie $7 D005061
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a Research Support, U.S. Gov't, P.H.S. $7 D013487
700    1_
$a Atzmon, Gil
700    1_
$a Arking, Albert
700    1_
$a Barzilai, Nir
700    1_
$a Dietz, Harry C
773    0_
$w MED00001092 $t Circulation research $x 1524-4571 $g Roč. 96, č. 4 (2005), s. 412-418
856    41
$u https://pubmed.ncbi.nlm.nih.gov/15677572 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200911 $b ABA008
991    __
$a 20200915104404 $b ABA008
999    __
$a ok $b bmc $g 1563273 $s 1103984
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2005 $b 96 $c 4 $d 412-418 $e 20050127 $i 1524-4571 $m Circulation research $n Circ Res $x MED00001092
GRA    __
$a DK 20541 $p NIDDK NIH HHS $2 United States
GRA    __
$a M01-RR12248 $p NCRR NIH HHS $2 United States
GRA    __
$a MH070172 $p NIMH NIH HHS $2 United States
GRA    __
$a P01 AG-03949-01A1 $p NIA NIH HHS $2 United States
GRA    __
$a R01 AG-18728-01A1 $p NIA NIH HHS $2 United States
LZP    __
$a Pubmed-20200911

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...